Skip to main content
Watch Insiders

Corporate insider profile

Mittie Doyle Insider Trades

Latest reported as Chief Medical Officer of Avalo Therapeutics, Inc. (AVTX).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,895,457.79
Latest transaction
Aug 28, 2026

Affiliated corporations

Reported company relationships

AVTXLatest reported

Avalo Therapeutics, Inc.

Chief Medical Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 28, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale679$20.00$13,580
Aug 17, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale1,000$20.00$20,000
Aug 10, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale679$20.00$13,580
Jul 27, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale1,000$20.00$20,000
Jun 30, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale4,654$20.00$93,080
Jun 23, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale1,450$18.00$26,100
May 28, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale679$16.00$10,864
May 15, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale3,000$18.76$56,280
May 6, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale108,234$20.61$2,230,367
Mar 16, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale25,492$16.15$411,607